Posts

7 days in healthcare (October 17th-23rd, 2022)

/in /by

 

Summary

From the point of view of biomedicine, the announced “vaccine against cancer” should be highlighted, which could be prepared before 2030. Although not strictly a vaccine, it represents a promising treatment against this disease based on mRNA technology, the same used for covid vaccine.

Regarding Global Health, an important announcement by the WHO about the dangers of a sedentary lifestyle, which could produce 500 million chronic patients in 2030. The WHO dedicates 2,600 million in its next strategy 2022-2026 for the eradication of polio .

Regarding international health policy, an important debate introduced by The Economist on the massive use of antidepressants, when only in 15% of cases do they have an effect other than placebo. Opioids in the United States and antidepressants worldwide are examples of the misuse of medications, which can lead to, and in many cases lead to, health problems. The post-pandemic horizon has generalized a hybrid work model (face-to-face and online) for office professionals.

If we talk about national health policy (Spain), the pressure on hospitals due to covid remains low, despite a slight rise in this disease. Intense debate on the flight of Spanish doctors to other countries, attracted by better salary and professional conditions. No matter how much the number of MIR vacancies and Faculties of Medicine increases, the problem will not be solved if working conditions are not acted upon. Teleconsultations seem to consolidate in Primary Care, already being more than 50% of the visits. The Trans law is the subject of great controversy. Most psychiatrists and psychologists, against. Obviously, we are in favor of the position of the WHO by removing from the list of diseases already in 2018 these cases of having a gender identity other than biological sex and wanting to change the morphology of their body. We welcome that there is a law on the subject as in most Western civilized countries. But one thing is that and another that 14-year-olds can choose sex without a psychological evaluation carried out by experts, who can rule out cases. Irreversible problems may occur. There is a certain consensus that the current wording of the law does not sufficiently protect minors.

In the field of companies, at the international level, we must welcome the first agreement with a pharmaceutical company (Novartis) to produce an anticancer drug as a generic that is still protected by patent, for its production in developing countries. As far as Spain is concerned, the continuous growth of health insurance should be highlighted, which in 2022 until September grows considerably more than the insurance as a whole.

Biomedicine

Global Health

International health policy

National health policy

Companies

7 days in healthcare (October, 10th-16th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, to review the advances in knowledge of the human organ that, to a large extent, remains a mystery, the brain: the implantation of human cells in mice, which can send signals and the creation of a kind of synthetic intelligence, by verifying that nerve cells in a dish can learn. In the United States, it is found that mortality from breast cancer has decreased a lot, due to early detection and better treatments. Something that is not exclusive to the United States and that surely also occurs in Spain.

As far as Global Health is concerned, the serious health problems, for very different reasons, in Pakistan, Somalia, Syria and Lebanon must be highlighted.

Regarding international health policy, there is great concern in the WHO and other organizations about the effects of persistent covid. Threat of hospitals in Germany by covid. The Economist introduces the debate on the legalization of cocaine, which it strongly defends, considering that the problems of an illegal market far outweigh those that could arise in a controlled market. Put the simile of whiskey and cigarettes.

If we talk about national health policy (Spain), the rise in the incidence of covid continues, although in Spain without notably affecting hospitals. Promising launch of the Neurotechnology Center in Madrid.

In the field of companies, at the international level, the WTO (World Trade Organization) continues with its efforts to free the patents of medicines related to covid. As far as Spain is concerned, HIPRA suffers a new delay in the approval of its vaccine by the EMA, which practically excludes it from the fourth dose vaccination campaign.

Biomedicine

Global Health

International health policy

  • European Union
    • A step forward towards a Europe of health. The reinforcement of the ECDC (European Center for Disease Prevention and Control), the EMA (European Medicines Agency) and the creation of the Health Emergency Preparedness and Response Authority, constitute important steps towards a European policy of health, something not contemplated in the founding European treaties (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01980-8/fulltext)
  • The debate on the legalization of cocaine
  • New Code of Medical Ethics
    • Approved the new International Code of Medical Ethics of the World Medical Association. After the initial version of this Code in 1949, a new wording has been approved at the General Assembly of the World Medical Association, held in Berlin in October 2022 (https://jamanetwork.com/journals/jama/fullarticle/2797507)

National health policy

Companies

 

 

7 days in healthcare (September 26th-October 2nd, 2022)

/in /by

Summary

From the point of view of Biomedicine, to review the advances, still to be confirmed, in the treatment of two terrible diseases: ALS and Alzheimer’s.

Regarding Global Health, concerns continue about the evolution of polio, whose eradication was announced in 2019, but which is reappearing in several countries.

Regarding International health policy, it is worth noting the similarities between the covid-zero policy in China and the era of prohibition in the United States, something pointed out by The Economist. Very worrying is the “burnout” of doctors, a phenomenon highlighted by the New York Times in the United States, but which seems to be universal.

If we talk about National health policy (Spain), the debates on the Equity Law continue. The update of the RD on the minimum data set of the SNS leaves out the private sector, despite the opposition of the POP, IMAS Foundation, IDIS Foundation and ASPE. It is a modification of a 2010 RD, but in twelve years the private sector has developed a lot and it is no longer so easy to leave it out in certain decisions. The Senate rejects the PP’s motion to facilitate access to medicines and reduce the time it takes to join the SNS. Surely the motion of the PP was too vague and, at this point, it is necessary to explain very well the “what” and the “how” of any proposal.

At the corporate level, at the international level, big rise in Biogen shares, spurred by what appear to be hopeful results from its Alzheimer’s drug. At the national level, there are rumors that KKR and CVC could be trying to buy Quirónsalud, currently in the hands of the German group Fresenius, which has recently changed its CEO. The Murcian company Vócali develops the Inbox Medical software for transcription of medical reports.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (August 29th-September 4th, 2022)

/in /by

 

Summary

From the point of view of Biomedicine, the great impact of the study by scientists from the University of Oviedo, who have studied the genes of a species of jellyfish, which incorporates rejuvenation elements in its life cycle, should be highlighted.

With regard to Global Health, historical decline in life expectancy in the United States, which went to 76 years in 2021, compared to 79 in 2019. The covid, the main responsible, although not the only one. Presumably we will see a similar phenomenon in Europe and in Spain.

Regarding International health policy, both the FDA and the EMA approve the covid vaccine boosters, despite some questions that have been pointed out by the journal Science. In the UK, long waiting lists in the public sector are leading to a boom in direct payment systems for healthcare.

If we talk about national health policy (Spain), the two most relevant issues are the approval of the bill that creates the Spanish Public Health Agency, subject to hearing and public information; and the draft Law on Abortion, which has very controversial elements, such as abortion in women aged 16-18 without information or parental consent; conscientious objection for doctors (on whose regulation the WTO has ruled negatively); the obligation to carry out this practice in public centers; and the dispensing of the morning after pill. Surprising statements by the President of the Community of Madrid, who attributes the shortage of doctors to the lack of Faculties of Medicine, contrary to what had been the opinion of the State Confederation of Medical Students and the Conference of Deans of Faculties of Medicine, with the support of the Forum of the Medical Profession. And the fact that only South Korea surpasses Spain in the ratio of Faculties of Medicine per million inhabitants.

In the field of companies, health has jumped into the metaverse with a business of 5,060 million dollars, although we will have to be very attentive to what we call metatarsus. HIPRA starts a trial to study its covid vaccine as a fourth dose.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

 

 

7 days in healthcare (August 21st-28th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, the very encouraging results of the polypill published by a Spanish group led by Valentin Fuster should be highlighted. The Economist underlines the great future of gene therapies in medicine, with a list of diseases for which there is a therapy or is in advanced study.

Regarding Global Health, The Lancet publishes a report with some conclusions and lessons regarding future pandemics.

As for International Health Policy, both monkeypox and covid are plummeting in Europe. The controversial annulment of the Roe v Wade ruling in the United States, which leaves the right to abortion to the criteria and regulation of the states, continues to be talked about. American companies, including Walmart, the largest American employer, introduce this benefit for women, regardless of the state where they work.

If we talk about National Health Policy (Spain), covid continues to drop and especially the number of cases in the ICU. The Government approves the bill that creates the Public Health Agency, probably the largest, if not the only, far-reaching measure after the pandemic. The text of the law is not yet public, and therefore important aspects such as governance and functions are not known. The location is not known either, although the Government has advanced that it would not be in Madrid, which is not without controversy either. Next week the government will approve the abortion law, according to a text promoted by Podemos.

In the field of companies, Moderna’s lawsuit against Pfizer and BioNTech has been shocked, which it accuses of plagiarism of its mRNA technology in the covid vaccine. Amazon closes its telecare service, which once again demonstrates the difficulties of the large technology platforms in finding an adequate strategy for health, a sector in which they want to be above all else. In Spain, the export of drugs manufactured in Spain grows by 60% in one year.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

 

 

 

7 days in healthcare (August 8th-14th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, there seems to be a glimpse of a new drug to prevent the transmission of HIV/AIDS, for which there are problems in obtaining an affordable price. Animal testing is the basis for certain advances in medicine. This can be overcome with certain new discoveries, according to the company Lift Sciences.

Regarding Global Health, two key issues: a new zoonosis (“Langya”) appears in China, as published in the NEJM. In certain developed countries it seems that polio, which was considered eradicated, is making a comeback.

Regarding international health policy, the approval of the Inflation Reduction Act (IRA) of 2022 in the United States, about Climate, Fiscal and Health will have a very important impact. Aside from expanding access to insurance through the Affordable Care Act (Obamacare), surely the most far-reaching impact will be on the pharmaceutical industry. Gradually, Medicare will be able to negotiate the price of medicines with the pharmaceutical industry, something that until now it could not do. This radically changes the business model of the pharmaceutical industry, which was based on two things: the protection of intellectual property through patents; and the existence of free prices with high margins in the United States (the largest pharmaceutical market) and regulated prices and lower margins in the rest of the world. A substantial change that will most likely have a global impact. It may also curb the escalation of health care spending in the United States. We’ll see if this doesn’t upset the fast pace of drug innovation.

If we talk about national health policy (Spain), the good news is that, as in all of Europe, covid continues to decrease in incidence, although it is still a worrying disease, due to the number of hospitalized cases and mortality.

In the field of companies, trials for new covid variants begin by BioNTech and Pfizer. More than 2,300 Spanish pharmacies can now sell through the Glovo platform and soon Uber, although only parapharmacy products, not prescription drugs.

Biomedicine

Global health

International health policy

National health policy

Companies

 

 

 

 

 

7 days in healthcare (January 17-23, 2022)

/in /by

 

SUMMARY

From an international point of view, the article published in The Lancet should be highlighted, in which mortality due to antimicrobial resistance, one of the most important causes of death in the world, is analyzed at a global level. Also the demand of the British Medical Journal that the scientific community have access to all the original data on the clinical trials of vaccines, since at this time these data are only accessible to employees of pharmaceutical companies. The Economist analyzes if the mandatory nature of the vaccine works, concluding that it does. It looks like all the COVID restrictions in England are going to end soon. The European Union gives more powers to the EMA, in case of having to manage future health crises.

As for the national news, the pandemic is still unchecked, in very high numbers and with high mortality; the debate on treating the covid as influenza continues, with opposing positions, those who are against it and those who defend it; the Ministry of Health wants to advance in the recertification, in dialogue with the FACME and the Organization of Medical Orders; The situation of health insurance in 2021 is presented, which did not stop growing, until the sector as a whole reached a turnover of close to 10,000 million euros; the Madrid College of Physicians signs a controversial agreement with UNIPROMEL, in theory to “defend doctors in free practice”, but, more possibly, with the intention of reinforcing the current weakened board of directors.

As far as companies are concerned, perhaps the most outstanding news is the sale by IBM of Watson Health, the artificial intelligence solution, designed to solve diagnostic and therapeutic problems, which had had so many problems in some centers such as MD Anderson from Houston. Although it was a good and ambitious idea, it was possibly ruined by short-termism, hyperselling and not taking enough into account the complexities of medicine and medical practice.

INTERNATIONAL NEWS

  • The Lancet publishes an article on the mortality of antimicrobial resistance. 204 countries and territories are analyzed in 2019. 4.95 million deaths from antimicrobial resistance were found in 2019. Antimicrobial resistance is one of the most important causes of death in the world (The Lancet, 20 January 22)
  • The British Medical Journal, after the Tamiflu experience, asks that the original data (raw data) from the clinical trials of vaccines be accessible to all researchers, not just those from the pharmaceutical industry, as is the case now (BMJ, January 19, 22)
  • The WHO gives the green light to the wider use of the third dose against COVID (FT, January 21, 22)
  • The fourth dose of the vaccine, infective in the extension of the “ómicron” variant, according to an Israeli study (FT, January 18, 22)
  • The Economist analyzes if the compulsory nature of the vaccine works. After analyzing the cases of Canada, France, Italy and Germany, he concludes that it works (The Economist, January 22, 22)
  • The covid passport strengthens the economy and vaccination (FT, January 18, 22)
  • Bill Gates warns against a pandemic potentially worse than COVID and calls on governments to spend billions of dollars to prevent it. He also says that this effort can contribute to improving the prevention and treatment of current extended diseases: HIV, tuberculosis, malaria (FT, January 19, 22)
  • All restrictions in England may end in March, according to the British Prime Minister’s plans (The Guardian, 17 January 22)
  • The EU approves the reform that gives more powers to the EMA in the management of future health crises (The Objective, 20 January 22)
  • Italy registers an increase in vaccination, after making it mandatory for those over 50 years of age (El País, January 17, 22)

NATIONAL NEWS

  • Situation of the pandemic

o COVID, still unchecked, breaks a new record of 3,418 cases per 100,000 inhabitants (El País, January 21, 22)

o The ICUs are at the limit of their structural capacity but far from the worst moments (El País, January 17, 22)

  • Debate about dealing with the covid as if were “flu”

o Two opposing positions:

 “Gripalizing the covid or how to believe we are winners”, article by Santiago Cervera, January 15, 22)

 Antonio Zapatero is committed to self-care and not to restrictions (El Español, January 17, 22)

  • Sick leave

o Processed 21,000 sick leaves and registrations in Madrid in the first days of the new system (El País, January 20, 22)

o The doctors accuse Escrivá of violating the law with the casualties, by giving in the same act for 7 days (La Razón, January 17, 22)

  • Recertification

o The Ministry of Health commits with FACME and the WTO to promote professional recertification (Acta Sanitaria, January 21, 22)

  • Situation schools

o The avalanche of school confinements puts families on the ropes (El País, January 21, 22)

  • Health insurance

o Health insurance grows by 4.93% in 2021 and totals 9,849 million euros (Acta Sanitaria, January 18, 22)

o According to forecasts by Javier Murillo, health insurance will grow in 2022 by around 5.5-6% (presentation at ICEA)

o MJ Montero (Finance Minister): great support for the MUFACE system (MUFACE Magazine, nº 252, winter 2021)

  • Other issues

o Organ transplants overcome the slump of 2020 and grow 8% in 2021 (El País, January 21, 22)

o Argimón presents the 2021-2025 health plan (Consalud, January 20, 22)

o Health, forced by Transparency to deliver to Farmaindustria the minutes of the Pharmacy Commission of the Interterritorial Council (diariofarma, January 16, 22)

o The MIR exam will bring together candidates from 4 continents and 88 countries (redacción Médica, January 20, 22)

o The Madrid College of Physicians signs an agreement with UNIPROMEL, “to defend free practice physicians” (Official Note ICOMEM, January 21, 22)

o Health awards 81 linear accelerators, in compliance with the INVEAT plan, three lots: Ab Salud, Varian and Elekta (ConSalud, January 18, 22)

COMPANIES, EMPLOYERS AND MAIN ACTORS IN HEALTH

  • IBM sells Watson Health to an investment firm. The sale was preceded by resounding failures of this artificial intelligence tool for medical diagnosis and treatment (WSJ, January 21, 22)
  • Moderna intends to launch a joint COVID-flu vaccine in two years (The Guardian, January 17, 22)
  • Djokovic has 80% of the shares in a Danish biotech firm (QuantBioRes) that intends to release a vaccine against COVID (The Guardian, January 19, 22)
  • Pfizer becomes the largest provider of the pandemic and it is estimated that it will double its income (eldiario.es, January 17, 22)
  • Pfizer, AstraZeneca and the Chinese Sinopharm and Sinovac will manufacture 70% of the COVID vaccines (CincoDías, January 20, 22)
  • Merck entrusts the manufacture of its pill against COVID to 27 manufacturers (PlantaDoce, January 20, 22)
  • More than 100 laboratories in Asia and Africa could manufacture vaccines for Pfizer and Moderna (El Independiente, January 19, 22)
  • The “telecos” take advantage of the pandemic to add clients in telemedicine (El Independiente, January 19, 22)
  • AstraZeneca, the most widely used COVID vaccine in the world that is no longer administered in Spain (El Español, January 21, 22)
  • St John of God (important hospital network in Spain, until now divided into three “provinces”) consolidates its management structure at the national level (Acta Sanitaria, January 20, 22)
  • Acciona, Sacyr and OHLA bid for a new hospital in Chile for 265 million euros (PlantaDoce, January 16, 22)
  • Dental Residency, objective by 2022 to double billing and provide coverage to 250,000 residents (PlantaDoce, January 20, 22)
  • The EMA asks HIPRA to show greater efficiency than Pfizer, if it wants to be part of the European Union’s portfolio (El Economista, January 18, 22)
  • HIPRA will carry out the last clinical trial of its vaccine at HM Hospitals (El Economista, January 17, 22).
  • Viamed is preparing an offer for one of the “Catholic” hospitals in Madrid: San Francisco and Beata María Ana (Sanifax, January 21, 22)
  • ASISA renews its Board of Directors with three members, one internal and two independent directors (Europa Press, January 20, 22)
  • Mercadona offered the Government to sell tests in its establishments at 2.90 euros. The Government preferred to keep pharmacies as the only test point of sale (Sanifax, January 20, 22)
  • Lilly publishes an overview of start ups in health in Spain (Lilly, January 22)

7 days in healthcare (December 27, 2021-January 2, 2022)

/in /by

 

 

SUMMARY

 

From an international point of view, to highlight the 50th anniversary of “Médecins sans Frontières”; also the impressive success of vaccines that saved hundreds of thousands of lives globally; the great expansion of COVID by the “omicron” variant, which is leading to the record of infections in many countries; as well as the strengthening of three important institutions linked to health in the European Union: the ECDC, the EMA and the HERA. To verify that COVID produced more deaths globally in 2021 than in 2020.

With regard to national news, it should be noted that Spain leads the number of infections in Europe, in the midst of a collapse of Primary Care and pressure on hospital emergencies and, little by little, also on hospitalization areas and ICUs. Antigen tests are scarce and, in addition, they are very expensive. The government submits the MUFACE model to AIReF’s evaluation, which is good news, if that evaluation is done rigorously. The Community of Madrid is tackling a very difficult project: the creation of a health purchasing center. Once again, it is necessary to do it very well, obtain the synergies of the large public buyer, without altering the autonomy of the centers and without evaluating exclusively the price of the items, but other elements (quality, safety for the patient, technical service, etc.)

In relation to companies, it should be noted that this year we will probably see the first Spanish vaccine (HIPRA) in operation, also that El Corte Inglés, Carrefour and Alcampo offer to sell COVID tests in their establishments, something until now reserved for pharmacies.

INTERNATIONAL NEWS

 

  • Eight medical advances (not related to COVID) in 2021: 1. The structure of proteins, within reach of an algorithm; 2. Live CRISPR; 3. Closer to the chimera (monkey-human chimeras); 4. New and controversial drug against Alzheimer’s: 5. Neuroprosthesis to communicate; 6. Avoid relapses into depression; 7. Impact of salt on strokes; and 8. Triple “jump” in child transplantation (Diario Médico, Dec 31 21)
  • 50 years after the creation of “Médecins sans Frontières” (Doctors without Borders), founded in 1971, as an independent non-governmental association, currently formed by 25 national or regional associations, which works in more than 70 countries and employs in around 45,000 people (The Lancet, 1 Jan 22)
  • One year of COVID vaccines. In the USA alone there are more than 200 million vaccinated, and the vaccine has prevented millions of COVID-19 cases, thousands of hospitalizations and saved hundreds of thousands of lives. An unprecedented success. Experience indicates that vaccines alone do not save lives, it is the vaccination process that saves them (including manufacturing, distribution and administration), which requires robust organizations (JAMA, Dec 21, 21)
  • The Wellcome’s Global Monitor 2020, which assesses trust in science and scientists, is released. The survey covers 113 countries. Although with large regional differences, it is detected that confidence in science grew during the pandemic (The Lancet, 1 Jan 22)
  • COVID leaves more deaths in the world in 2021 than in the year of its outbreak (El Confidencial, 1 Jan 22)
  • The “omicron” variant produces records of infections in 20 countries, among which are Australia, Canada, Denmark, Ireland, Italy, Spain, Switzerland, the United Kingdom and the United States (FT, Dec 31 21)
  • The United States reduces the period of isolation due to COVID to 5 days (FT, Dec 28 21)
  • The WHO warns of a “tsunami of cases” due to the “omicron” and Delta variants (FT, Dec 29 21)
  • WHO says the pandemic may overwhelm health systems, as cases reach records in Europe (FT, The Guardian, Dec 29 21)
  • Shortage of COVID tests in the UK, as cases rise (FT, Dec 29 21)
  • Europe: promoting the “European Health Union”, reinforcing the ECDC (European Center for Disease Prevention and Control) and the EMA (European Medicines Agency) and activating the creation of the HERA (European Preparedness and Response to Health Emergencies Agency), which is expected to start operating in early 2022, with an initial budget of 6,000 million euros, although it is expected to reach 30,000 million, with contributions from the States and the private sector (ConSalud, 30 Dec 21)
  • Persistent COVID and its more than 200 sequels already have an official definition (El País, Dec 28 21)
  • According to a survey, one in four Britons do not believe that the NHS can serve them well, which is surprising given the extraordinary prestige of the NHS so far in the UK (The Guardian, 26 Dec 21)

NATIONAL NEWS

  • “Redacción Médica” analyzes the 10 highlights of 2021: 1. COVID has not abandoned us; 2. Filomena tests the capacity for healing; 3. Relief in the Ministry of Health: Darias instead of Illa; 4. Euthanasia, regulated by Law; 5. Spanish stamp for the first public CART therapy in Europe; 6. Controversial choice of MIR places; 7. Industry is ahead of the virus, with an arsenal of vaccines and treatments; 8. Muface “illuminates” the future of health mutualism; 9. Several strategies in Spanish health: Cancer, Mental Health and Primary Care; and, 10. Various variants of COVID (Redacción Médica, Dec 31 21)
  • Elements that are considered essential for 2022: COVID, Primary Care and Mental Health. The Center for Public Health and improvements for professionals is also expected (ConSalud, 1 Jan 22)
  • Spain closes 2021 at the head of infections in Europe (Diario Médico, Dec 31 21)
  • On December 30, 21, the COVID rate reached 1,775 cases per 100,000 inhabitants. Despite everything, no new official information on the number of cases will be published until January 3 (El Español, Dec 31 21)
  • The collapse in primary care due to COVID leads to hospital emergencies (eldiario.es, Dec 26 21)
  • Health and communities agree to reduce the COVID quarantine period to 7 days (La Razón, Dec 29, 21)
  • Antigen tests in Spain: scarcity and high prices, while in other countries (France and the United Kingdom) they are free (El Debate, 1 Jan 22)
  • The Spanish Medicines Agency advises not to buy antigen tests online (El Debate, Dec 28 21)
  • The Council of Ministers endorses the Plan to improve Primary Care (Health Act, Dec 28 21)
  • Numerous unions and scientific societies (especially those linked to Primary Care) demonstrate against the approved Plan (Consalud, Dec 31 21)
  • The MUFACE model will be subject to review, the government instructs AIReF to evaluate it (El Español, Dec 28 21)
  • Very important draft bill of the Community of Madrid: “Draft Bill of urgent measures to promote economic activity and modernization of the Administration of the Community of Madrid”. Article 44 of the preliminary draft develops the Sanitary Contracting Agency of the Community of Madrid, which becomes a health purchasing center for Madrid. It is more than foreseeable that this is a controversial law with suppliers. (Draft project disseminated by the Community of Madrid: https://www.comunidad.madrid/transparencia/sites/default/files/2._anteproyecto_ley_omnibus_texto_completo_21-12-2021_0.pdf)

COMPANIES, EMPLOYERS AND MAIN ACTORS IN HEALTH

 

  • 2022: the year in which the first Spanish vaccine will reach patients (El Español, Dec 30 21)
  • Private healthcare, years ahead of the SNS in telemedicine (Redacción Médica, Dec 29 21)
  • J&J (Janssen) Vaccine Protects Against Severe “Omicron”, Study Says (NYT, Dec 30, 21)
  • Teva found liable in the US opioid trial (NYT, Dec 30 21)
  • HM acquires a plot of land in Tres Cantos, for the construction of a university hospital (Acta Sanitaria, 23 Dec 21)
  • HM buys the Dr. Gálvez clinic in Malaga, the fourth clinic that the HM group buys in the region (Málagahoy, Dec 31 21)
  • Atrys has 100 million to buy health companies (El Economista, Dec 29 21)
  • Antigen test manufacturers (such as Abbott, Siemens Healthineers and Roche groups) end the year skyrocketing on the stock market (CincoDías, Dec 28, 21)
  • El Corte Inglés, Carrefour or Alcampo offer to sell antigen tests at their centers, according to their employer Anged (CincoDías, Dec 30 21)
  • Magnum Capital starts the international leap of its Miranza ophthalmology clinics: Portugal and Andorra (CincoDías, Dec 27 21)
  • The Jiménez Díaz Foundation leads for the sixth consecutive year the Hospital Excellence Index of the Coordinates Institute (ABC, Dec 27 21)